the majority of melanomas were reactive with a polyclonal antibody to s100 protein ( p-s100 ; 85 % ) , a monoclonal melanoma-specific antibody ( hmb-45 ; 88 % ) , and a monoclonal antibody to vimentin ( 90 % ) , and there were no differences in staining profiles for these antibodies by anatomic location .
C0003250
monoclonal
C0003241
antibodies